Factors affecting the quality of life in drug-resistant epilepsy patients
dc.authorid | GULDIKEN, Baburhan/0000-0002-9006-1880 | |
dc.contributor.author | Akdemir, Vedat | |
dc.contributor.author | Sut, Necdet | |
dc.contributor.author | Guldiken, Baburhan | |
dc.date.accessioned | 2024-06-12T11:00:31Z | |
dc.date.available | 2024-06-12T11:00:31Z | |
dc.date.issued | 2016 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | Epilepsy patients whose seizures cannot be controlled by treatment have a lower quality of life (QoL). The aim of the present study was to compare the potential factors affecting the QoL in patients who were seizure-free with medication or who had drug-resistant epilepsy. The study included 46 drug-resistant and 42 seizure-free epilepsy patients. The demographic and clinical features of the patients were investigated for their effects on patient QoL. The QoL was assessed by the QoL in Epilepsy Inventory-89 and depression was detected by the Beck Depression Inventory. The QoL was significantly lower in the drug-resistant patients than in the seizure-free epilepsy patients (p < 0.001). Depression, lower education level, and unemployment were associated with lower QoL scores (p < 0.001, p < 0.01, p < 0.001, respectively). After adjusting for lower education level and unemployment, depression remained as an independent factor affecting QoL (p < 0.05). In addition to their efforts to control and stop seizures, clinicians should remain aware of depression and treat it effectively to improve the QoL of drug-resistant epilepsy patients. | en_US |
dc.identifier.doi | 10.1007/s13760-016-0622-5 | |
dc.identifier.endpage | 518 | en_US |
dc.identifier.issn | 0300-9009 | |
dc.identifier.issn | 2240-2993 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 26943462 | en_US |
dc.identifier.scopus | 2-s2.0-84960103475 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 513 | en_US |
dc.identifier.uri | https://doi.org/10.1007/s13760-016-0622-5 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/20869 | |
dc.identifier.volume | 116 | en_US |
dc.identifier.wos | WOS:000387681300013 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer Heidelberg | en_US |
dc.relation.ispartof | Acta Neurologica Belgica | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Epilepsy | en_US |
dc.subject | Quality Of Life | en_US |
dc.subject | Depression | en_US |
dc.subject | Drug Resistance | en_US |
dc.subject | Depressive Symptoms | en_US |
dc.subject | Ratings | en_US |
dc.subject | Surgery | en_US |
dc.subject | People | en_US |
dc.subject | Impact | en_US |
dc.subject | Adults | en_US |
dc.subject | Identification | en_US |
dc.subject | Determinants | en_US |
dc.subject | Association | en_US |
dc.subject | Predictors | en_US |
dc.title | Factors affecting the quality of life in drug-resistant epilepsy patients | en_US |
dc.type | Article | en_US |